We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.48%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.3B
AUM Growth
+$225M
Cap. Flow
+$94.2M
Cap. Flow %
4.09%
Top 10 Hldgs %
40.24%
Holding
305
New
26
Increased
135
Reduced
93
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 10.28%
2 Healthcare 7.77%
3 Financials 4.92%
4 Industrials 4.71%
5 Communication Services 3.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKG icon
151
Packaging Corp of America
PKG
$21.8B
$954K 0.04%
7,042
-4,688
-40% -$674K
VOO icon
152
Vanguard S&P 500 ETF
VOO
$972B
$938K 0.04%
2,383
+261
+12% +$100K
DIA icon
153
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.6B
$931K 0.04%
2,698
+107
+4% +$36.5K
PCAR icon
154
PACCAR
PCAR
$69.8B
$898K 0.04%
15,101
-1,141
-7% -$69.9K
ESGE icon
155
iShares ESG Aware MSCI EM ETF
ESGE
$6.59B
$889K 0.04%
19,680
+4,561
+30% +$202K
LLY icon
156
Eli Lilly
LLY
$1.02T
$878K 0.04%
3,828
+14
+0.4% +$2.81K
XYZ
157
Block Inc
XYZ
$48.1B
$877K 0.04%
3,596
-51
-1% -$11.8K
TXN icon
158
Texas Instruments
TXN
$252B
$870K 0.04%
4,523
+241
+6% +$45.2K
SCHM icon
159
Schwab US Mid-Cap ETF
SCHM
$14.4B
$867K 0.04%
33,243
-1,131
-3% -$29.2K
FISV
160
Fiserv Inc
FISV
$28.2B
$863K 0.04%
8,073
-20
-0.2% -$2.33K
DEO icon
161
Diageo
DEO
$49.1B
$848K 0.04%
4,424
-150
-3% -$27.9K
TT icon
162
Trane Technologies
TT
$100B
$848K 0.04%
4,607
+355
+8% +$63.2K
IYE icon
163
iShares US Energy ETF
IYE
$1.73B
$824K 0.04%
28,314
-931
-3% -$25.9K
DUK icon
164
Duke Energy
DUK
$98.1B
$821K 0.04%
8,317
+11
+0.1% +$1.1K
ORCL icon
165
Oracle
ORCL
$366B
$812K 0.04%
10,429
-110
-1% -$8.61K
VBIV
166
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$810K 0.04%
8,056
+560
+7% +$54.6K
SPGP icon
167
Invesco S&P 500 GARP ETF
SPGP
$2.24B
$808K 0.04%
9,225
-1,820
-16% -$156K
VTI icon
168
Vanguard Morningstar Total Stock Market ETF
VTI
$656B
$801K 0.03%
3,594
-72
-2% -$15.6K
BCRX icon
169
BioCryst Pharmaceuticals
BCRX
$2.29B
$800K 0.03%
50,605
-1,157
-2% -$15.7K
D icon
170
Dominion Energy
D
$61.2B
$800K 0.03%
10,874
+655
+6% +$50.6K
MGK icon
171
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.2B
$794K 0.03%
17,155
-235
-1% -$10.3K
BLK icon
172
Blackrock
BLK
$169B
$779K 0.03%
890
+24
+3% +$20.3K
GLD icon
173
SPDR Gold Trust
GLD
$131B
$760K 0.03%
4,591
-466
-9% -$79.2K
SCHB icon
174
Schwab US Broad Market ETF
SCHB
$42.9B
$741K 0.03%
42,666
-1,116
-3% -$18.9K
IP icon
175
International Paper
IP
$21.9B
$727K 0.03%
12,527
+4
+0% +$228

Similar funds

Grimes & Company's Q2 2021 Portfolio in Review

As of Q2 2021, Grimes & Company held 305 positions worth $2.3B, up 11% from $2.08B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grimes & Company deployed $94.2M of net new capital in Q2 2021, opening 26 new positions and adding to 135 existing holdings. Its largest new stake was Invesco Ultra Short Duration ETF: 38,101 shares worth $1.92M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Expeditors International, an estimated $10.4M trimmed.

  • Grimes & Company's largest Q2 2021 buy was Invesco Ultra Short Duration ETF: 38,101 shares worth $1.92M.
  • Grimes & Company added most to State Street Technology Select Sector SPDR ETF in Q2 2021, an estimated $14.7M increase.
  • Grimes & Company's biggest Q2 2021 reduction was Expeditors International, cutting an estimated $10.4M.
  • Grimes & Company fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $10.4M.
  • Grimes & Company's ten largest holdings make up 40% of its $2.3B portfolio in Q2 2021.
  • Grimes & Company opened 26 new positions and closed 3 in Q2 2021.
  • Grimes & Company's portfolio value rose 11% quarter-over-quarter to $2.3B.

Based on Grimes & Company's 13F filing for Q2 2021, filed 4 Aug 2021.